Adobe

By Lizzy Lawrence

Oct. 16, 2025

FDA Reporter

Lizzy Lawrence

[email protected]

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53.

WASHINGTON — The Food and Drug Administration on Thursday announced the first nine recipients of the Commissioner’s National Priority Review vouchers, a program offering an expedited drug review to companies with products that align with the agency’s national health priorities. 

President Trump highlighted one of the recipients, EMD Serono, at a White House news conference on expanding access to in vitro fertilization on Thursday. EMD Serono agreed to lower the prices of its existing fertility drugs. In exchange, the company received a voucher for Pergoveris, which stimulates egg development and has already been approved in 74 countries. 

Advertisement

The other drugs on the list are: 

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe
, ,
Submit a correction requestReprints

  1. Lizzy Lawrence

    FDA Reporter

    Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53.